CRD-B NYSE Week ended 31 Jul 2026

Weekly Investor Report

Crawford & Company · Financial Services · Insurance Brokers

Open interactive chart View report data
Latest close 10.07 USD
-0.4% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -0.7% below the Trend Line and sits at 52.2% of its 52-week range. The latest completed week returned -0.4%, after a -4.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers. The latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal.

Setup score 38 out of 100
Latest Close 10.07 USD 31 Jul 2026
1W Return -0.4% latest completed week
4W Return -4.0% short-term follow-through
12W Return 8.4% quarterly tape
Trend Breadth 32.7% 17 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.4% Latest completed week; four-week move -4.0%. Indicator stack 18/48 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 51/100 44 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -0.7% below the Trend Line and sits at 52.2% of its 52-week range. The latest completed week returned -0.4%, after a -4.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4812-week average 0.27

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.48Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.0% over four weeks, 8.4% over 12 weeks, and 11.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-0.4%
4W-4.0%
12W8.4%
26W-0.8%
52W11.3%
Active trend streak0 weeks
Active weeks in one year17
Trend breadth32.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.23Latest activity-pressure read.
Pressure change-75.4%Four-week change in activity pressure.
Leadership-8.73Latest relative-leadership reading.
RS change-51.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength82/100Blend of value, momentum, and quality. Underlying universe rank 19; rank 1 is best.
Value85/100Relative valuation strength. Underlying universe rank 16; rank 1 is best.
Quality65/100Profitability and accounting quality. Underlying universe rank 36; rank 1 is best.
Momentum29/100Medium-term price momentum. Underlying universe rank 72; rank 1 is best.
Growth2/100Revenue and earnings growth. Underlying universe rank 99; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework70/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
27.6x
Price divided by trailing earnings.
Price / sales
0.4x
Market value relative to trailing revenue.
EV / EBITDA
8.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
18.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
26.3%
Gross profit retained from each unit of revenue.
Operating margin
3.7%
Operating profit retained from revenue.
Free-cash-flow margin
10.1%
Free cash flow generated from revenue.
Return on invested capital
6.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-4.0%
Latest one-year revenue growth.
EPS growth
-41.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
62.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
3.0%
Cash dividends relative to market value.
Buyback yield
2.0%
Net share repurchases relative to market value.
Shareholder yield
5.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity0 / 10

0 acquisitions and 10 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment51/100

Weighted news tone is neutral across 44 relevant articles.

3 positive · 40 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-12.5%Distance below the 52-week high.
13-week volatility3.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+9.1%Week of 22 May.
Worst week-9.5%Week of 13 Mar.
Latest week-0.4%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains5
Flat weeks0
Modest losses12
Sharp losses3
Recent vol3.7%13-week weekly-return volatility.
Base vol4.7%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape36/100

Trend, activity pressure, participation, and risk combine to a 36/100 tape read.

 Indicator analysis31/100

Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.

Activity pressure 0.48; No reversal markers Factors66/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 23; Small Cap Core rank 17 SVQF70/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 302.5 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment51/100

Weighted news tone is neutral across 44 relevant articles.

Crawford & Company Board Increases Quarterly Dividends Insiders0 / 10

0 acquisitions and 10 disposals in the latest 180-day insider tape.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202610.07 USD-0.4%10.14 USD9.85 USD0.23-8.7318.3KOff
24 Jul 202610.11 USD-1.2%10.14 USD9.84 USD0.42-7.5119.4KOff
17 Jul 202610.23 USD1.1%10.17 USD9.82 USD0.64-7.2637.3KOff
10 Jul 202610.12 USD-3.5%10.18 USD9.80 USD0.75-9.9613.6KOff
3 Jul 202610.49 USD-3.3%10.20 USD9.78 USD0.94-5.7517.8KOff
26 Jun 202610.85 USD4.2%10.19 USD9.77 USD0.88-0.6722.0KOff
19 Jun 202610.41 USD-3.5%10.17 USD9.75 USD0.59-7.1316.5KOff
12 Jun 202610.79 USD4.7%10.17 USD9.74 USD0.33-3.2120.2KOff
5 Jun 202610.31 USD2.8%10.15 USD9.72 USD-0.24-7.1027.1KOff
29 May 202610.03 USD-2.4%10.15 USD9.71 USD-0.72-12.2529.0KOff
22 May 202610.27 USD9.1%10.14 USD9.69 USD-1.01-9.1821.0KOff
15 May 20269.42 USD1.4%10.13 USD9.68 USD-1.19-16.3345.1KOff
8 May 20269.29 USD-2.5%10.14 USD9.67 USD-1.01-17.8444.7KOff
1 May 20269.53 USD-3.4%10.15 USD9.66 USD-0.81-14.2823.6KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.